Toxicology – Amphetamines

Core Concept

Amphetamines are central nervous system stimulants and sympathomimetic drugs. They include prescription medications as well as illicitly manufactured stimulants.

Therapeutic amphetamine preparations are used mainly for:

• Attention-deficit/hyperactivity disorder (ADHD)
• Narcolepsy
• Selected other indications

The characteristic overdose syndrome is a sympathomimetic toxidrome:

Agitation + tachycardia + hypertension + mydriasis + diaphoresis + hyperthermia

Severe toxicity can progress to:

• Seizures
• Dangerous hyperthermia
• Rhabdomyolysis
• Dysrhythmias
• Myocardial ischemia
• Intracranial hemorrhage
• Shock
• Multiorgan failure

There is no specific antidote. Benzodiazepine-based sedation and aggressive supportive care are central to treatment.

Amphetamine-Type Stimulants

Clinically relevant agents include:

• Amphetamine
• Dextroamphetamine
• Mixed amphetamine salts
• Lisdexamfetamine
• Methamphetamine

Several drugs listed as “amphetamines” in older references are actually chemically or pharmacologically distinct stimulants or anorectic agents.

Many historical appetite suppressants listed in the source are also no longer commonly used because of safety concerns or regulatory changes.

Mechanism of Action

Amphetamines increase central and peripheral monoaminergic signaling.

Important mechanisms include:

• Increased presynaptic release of norepinephrine
• Increased release of dopamine
• Effects on serotonin at higher exposures or with particular agents
• Reversal/disruption of monoamine transport processes
• Intracellular effects involving vesicular monoamine storage

The older description of amphetamines as primarily direct α- and β-receptor agonists is incomplete.

Their major sympathomimetic effects arise predominantly from increased catecholamine availability.

Sympathomimetic Toxidrome

Typical findings include:

• Agitation
• Anxiety
• Restlessness
• Tachycardia
• Hypertension
• Mydriasis
• Diaphoresis
• Tremor
• Hyperreflexia
• Hyperthermia

Increasing toxicity can produce:

• Severe agitation
• Psychosis
• Seizures
• Cardiovascular complications
• Multiorgan injury

Amphetamine vs Antimuscarinic Toxicity

Both can produce:

• Agitation
• Tachycardia
• Mydriasis
• Hyperthermia

A useful distinction is:

Sympathomimetic → usually sweaty

Antimuscarinic → usually dry

Sympathomimetic patients often have marked diaphoresis and active bowel sounds, although no single physical finding is completely reliable.

Toxic Dose

There is no dependable universal toxic-dose threshold.

Severity varies with:

• Specific drug
• Formulation
• Route
• Patient size
• Individual sensitivity
• Chronic tolerance
• Coingestants
• Underlying cardiovascular disease

Therefore, management should be based on clinical toxicity rather than reported dose alone.

Tolerance in chronic users does not protect against catastrophic cardiovascular or hyperthermic complications.

Routes of Exposure

Amphetamine-type stimulants may be:

• Swallowed
• Insufflated
• Smoked
• Injected

The route influences:

• Speed of onset
• Peak concentration
• Duration
• Complication profile

Rapid-delivery routes can produce abrupt severe toxicity.

Neurologic Effects

Common manifestations include:

• Anxiety
• Agitation
• Tremor
• Headache
• Insomnia
• Hypervigilance
• Confusion

Severe toxicity can cause:

• Delirium
• Seizures
• Coma
• Intracranial hemorrhage
• Ischemic stroke

Psychiatric Effects

Amphetamine intoxication may produce:

• Paranoia
• Hallucinations
• Delusions
• Aggression
• Severe anxiety
• Stimulant-induced psychosis

Psychiatric symptoms may persist after peripheral sympathomimetic findings have improved.

Persistent psychosis requires reassessment for:

• Continued intoxication
• Sleep deprivation
• Coingestants
• Underlying psychiatric illness
• Other neurologic or metabolic disorders

Seizures

Seizures can result from intense CNS stimulation.

Complications include:

• Hypoxemia
• Lactic acidosis
• Hyperthermia
• Rhabdomyolysis
• Hyperkalemia
• Aspiration
• Acute kidney injury

Prompt control is essential.

Cardiovascular Effects

Common findings are:

• Sinus tachycardia
• Hypertension
• Palpitations

Severe toxicity may produce:

• Myocardial ischemia or infarction
• Coronary vasospasm
• Ventricular dysrhythmias
• Acute cardiomyopathy
• Acute heart failure
• Aortic dissection
• Shock

Young age does not exclude serious stimulant-associated cardiovascular disease.

Hypertension

Hypertension results from:

• Catecholamine excess
• Vasoconstriction
• Increased cardiac output
• Agitation

A major principle is:

Treat the hyperadrenergic state, not merely the blood-pressure number.

Sedation often improves both agitation and hypertension.

Severe Hypertensive Complications

Marked hypertension may contribute to:

• Intracranial hemorrhage
• Aortic dissection
• Myocardial ischemia
• Pulmonary edema
• Other end-organ injury

Persistent severe hypertension with acute organ injury requires titratable cardiovascular treatment in addition to sedation.

Hyperthermia

Severe hyperthermia is one of the most dangerous features of stimulant poisoning.

It can result from:

• Excessive motor activity
• Agitation
• Seizures
• Increased metabolic activity
• Catecholamine excess
• Impaired heat dissipation

Severe hyperthermia can rapidly produce:

• Rhabdomyolysis
• Hepatic injury
• Acute kidney injury
• Coagulopathy
• Cerebral injury
• Multiorgan failure

Hyperthermia Treatment

Management centers on:

• Rapid control of agitation
• External cooling
• Appropriate IV fluids
• Treatment of seizures
• Correction of physiologic abnormalities

Antipyretics such as acetaminophen do not correct stimulant hyperthermia because the problem is not an elevated hypothalamic fever set point.

Severe Agitation

Agitation itself can perpetuate:

Muscular activity → heat production → acidosis → rhabdomyolysis → worsening toxicity

Prompt sedation therefore has physiologic as well as behavioral importance.

Benzodiazepines

Benzodiazepines are generally first-line treatment for:

• Significant agitation
• Sympathomimetic excitation
• Seizures

They can also indirectly improve:

• Tachycardia
• Hypertension
• Hyperthermia caused by excessive muscular activity

Exact dosing should be titrated according to current emergency protocols and clinical response.

Refractory Agitation

Severe stimulant toxicity may require escalating sedation and intensive supportive management.

If dangerous agitation or hyperthermia cannot otherwise be controlled, advanced airway management and deep sedation may become necessary.

If neuromuscular paralysis is used:

Paralysis stops muscular activity but does not provide sedation or terminate cerebral seizure activity.

Adequate sedation and seizure treatment must continue.

Seizure Management

Benzodiazepines are first-line.

Refractory toxicologic seizures may require:

• Additional benzodiazepines
• Phenobarbital
• Appropriate anesthetic therapy for status epilepticus

Phenytoin – Modern Correction

The older recommendation to add phenytoin routinely is outdated.

Phenytoin is generally not preferred for toxin-induced seizures, because it does not effectively address many toxicologic seizure mechanisms.

Rhabdomyolysis

Rhabdomyolysis can result from:

• Hyperthermia
• Severe agitation
• Prolonged muscular activity
• Seizures
• Prolonged immobilization

Evaluate significant cases with:

• CK
• Potassium
• Creatinine
• Urinalysis
• Serial renal function

Treatment emphasizes appropriate fluid therapy and correction of electrolyte abnormalities.

Urinary Alkalinization

Routine urinary alkalinization is not recommended for stimulant-associated rhabdomyolysis.

It has not demonstrated clear benefit over appropriate supportive fluid management and can produce electrolyte and acid–base complications.

Renal Injury

Acute kidney injury may result from:

• Rhabdomyolysis
• Hyperthermia
• Hypotension
• Dehydration
• Severe systemic toxicity

Urine output and renal function should be monitored in severe poisoning.

Hepatic Injury

Severe hyperthermia and systemic toxicity can cause:

• Marked aminotransferase elevation
• Hepatic necrosis
• Acute liver failure

Liver injury is particularly concerning when accompanied by:

• Coagulopathy
• Hypoglycemia
• Lactic acidosis
• Encephalopathy

Coagulopathy

Extreme hyperthermia can trigger systemic coagulation abnormalities, including a DIC-like syndrome.

Monitor coagulation studies when severe hyperthermia or multiorgan injury develops.

Pulmonary Complications

Severe stimulant poisoning may cause:

• Aspiration
• Pulmonary edema
• Acute lung injury
• Respiratory failure

Respiratory compromise may also occur secondary to:

• Seizures
• CNS deterioration
• Severe cardiovascular toxicity

Acid–Base Disturbances

Lactic acidosis can result from:

• Severe agitation
• Seizures
• Hyperthermia
• Tissue hypoperfusion

Improvement often follows control of muscular activity, cooling, and restoration of perfusion.

Persistent severe acidosis should prompt investigation for shock, ongoing seizures, hyperthermia, or coingestants.

Electrolyte Abnormalities

Possible abnormalities include:

• Potassium disturbances
• Sodium disturbances
• Dehydration-related abnormalities

Electrolytes should be monitored closely in severe hyperthermia, seizures, or rhabdomyolysis.

Diagnosis

Amphetamine toxicity is primarily a clinical diagnosis.

Important information includes:

• Substance used
• Route
• Approximate timing
• Formulation
• Coingestants
• Prescription versus illicit source
• Duration of symptoms

Treatment should not wait for a urine drug screen when the clinical syndrome is convincing.

Urine Amphetamine Screening

Immunoassay drug screens have important limitations.

Possible problems include:

• False-positive results
• False-negative results
• Cross-reactivity with medications
• Inability to establish degree of intoxication
• Inability to prove that detected drug caused the current syndrome

A positive urine result indicates exposure within the detection window, not necessarily current clinical toxicity.

Confirmatory mass-spectrometric testing may be used when definitive identification matters.

Laboratory Evaluation

Minor uncomplicated intoxication may require limited testing.

Significant toxicity may warrant:

• Electrolytes
• Bicarbonate
• Creatinine
• Glucose
• CK
• Liver tests
• Blood gas and/or lactate
• Coagulation studies in severe hyperthermia
• Urinalysis

Intentional overdose may also require evaluation for important occult coingestants.

ECG and Cardiac Evaluation

Obtain an ECG when clinically significant toxicity is present.

Continuous monitoring is appropriate for:

• Severe tachycardia
• Chest pain
• Significant hypertension
• Dysrhythmia
• Hyperthermia
• Severe intoxication

Chest pain or ischemic findings should prompt appropriate evaluation for acute coronary injury.

Neurologic Imaging

Head CT is not required simply because a patient used amphetamines.

It becomes important when there is:

• Severe or unusual headache
• Focal neurologic deficit
• Persistent altered consciousness
• Suspected intracranial hemorrhage
• Trauma
• Seizure with concerning features

Lumbar puncture is likewise based on the differential diagnosis rather than routinely performed for stimulant intoxication.

Initial Management

Priorities are:

Airway/breathing → control agitation/seizures → measure core temperature → assess circulation → rapidly cool severe hyperthermia → identify end-organ injury

Benzodiazepine-based sedation is a central early intervention.

Hypertension Management

Many patients improve substantially after:

• Sedation
• Reduced stimulation
• Control of hyperthermia

Persistent severe hypertension with end-organ injury may require a short-acting titratable antihypertensive/vasodilator chosen according to the clinical problem.

The historical reliance on nitroprusside as the default drug is no longer necessary because several titratable agents are available.

β-Blockers – Important Nuance

Older teaching warned against every β-blocker in stimulant toxicity because of theoretical “unopposed α stimulation.”

Modern evidence is more nuanced and does not support treating all β-blockers as universally contraindicated.

However, in acute sympathomimetic poisoning:

• Sedation remains foundational.
• Drug selection should match the cardiovascular complication.
• Pure β-blockade is generally not the first reflexive treatment for an undifferentiated hyperadrenergic patient.

Management of myocardial ischemia, dysrhythmia, or severe hypertension should follow current toxicology/cardiology guidance.

Hypotension

Hypotension in severe poisoning may indicate:

• Volume depletion
• Hyperthermic collapse
• Cardiomyopathy
• Dysrhythmia
• Acidosis
• Multiorgan failure
• Coingestion

Treatment depends on the cause.

Appropriate crystalloid may be given when volume depletion is present, while persistent shock may require vasopressors and assessment of cardiac function.

Routine Trendelenburg positioning is obsolete.

GI Decontamination

Do not induce vomiting.

The historical routine use of gastric lavage is also obsolete.

A single dose of activated charcoal may occasionally be considered after a substantial recent oral ingestion if:

• Presentation is early
• The airway is safe
• The expected benefit outweighs aspiration risk

It should never delay treatment of agitation, seizures, hyperthermia, or cardiovascular instability.

Drug Packets

Suspected internal concealment of stimulant packets is a separate clinical problem.

Distinguish:

• Body packers – planned ingestion of multiple well-wrapped packets
• Body stuffers – hurried concealment of fewer, less securely wrapped packets

Packet rupture can cause abrupt life-threatening sympathomimetic poisoning.

Asymptomatic intact body packers may be candidates for monitored whole-bowel irrigation according to specialist protocols.

Packet rupture or severe toxicity may require urgent surgical and critical-care management.

Imaging for Drug Packets

The historical recommendation for routine abdominal radiographs is incomplete.

CT is generally more sensitive than plain abdominal radiography for detecting body-packing packets.

A negative plain film does not reliably exclude concealed packets.

No Specific Antidote

There is no direct antidote for amphetamine poisoning.

Treatment is based on:

• Sedation
• Cooling
• Seizure control
• Cardiovascular support
• Management of rhabdomyolysis
• Treatment of organ complications

Observation

The historical universal 4–6-hour observation rule is too rigid.

Duration depends on:

• Immediate-release versus extended-release formulation
• Specific drug
• Route
• Amount
• Clinical symptoms
• Coingestants
• Persistent psychiatric symptoms
• Vital signs
• Evidence of end-organ injury

Long-acting or modified-release products may produce prolonged toxicity.

Admission

Hospital admission is appropriate for clinically significant:

• Persistent agitation
• Recurrent seizures
• Hyperthermia
• Persistent severe tachycardia or hypertension
• Dysrhythmia
• Chest pain or ischemia
• Rhabdomyolysis
• Acute kidney injury
• Hepatic injury
• Coagulopathy
• Altered mental status

Severe hyperthermia or multiorgan toxicity generally warrants intensive care.

Chronic Stimulant Use

Long-term or repeated use can be associated with:

• Weight loss
• Sleep deprivation
• Psychiatric symptoms
• Cardiomyopathy
• Hypertension
• Vascular complications
• Dental and nutritional problems depending on circumstances
• Substance-use disorder

Injection additionally creates risks unrelated to the stimulant molecule itself, including:

• Endocarditis
• Abscess
• Blood-borne infections
• Sepsis

Stimulant Withdrawal

After prolonged heavy use, abrupt cessation can produce:

• Fatigue
• Hypersomnia
• Depressed mood
• Increased appetite
• Psychomotor slowing or agitation
• Craving

Severe depression and suicidality require direct assessment.

Withdrawal is generally not characterized by the autonomic instability seen with alcohol or sedative-hypnotic withdrawal.

Pregnancy

The historical FDA pregnancy letter categories are obsolete.

Amphetamine exposure during pregnancy should be assessed according to:

• Therapeutic versus nonmedical exposure
• Dose and frequency
• Maternal cardiovascular effects
• Nutrition
• Other substances
• Obstetric status

Severe maternal hyperthermia, hypertension, hypoxemia, or seizures require prompt treatment because maternal instability threatens fetal perfusion and oxygenation.

Safeguarding

Rigid age-based assumptions about neglect, abuse, or intentional poisoning are outdated.

Pediatric exposure should instead be evaluated according to:

• Developmental ability
• Accessibility
• Exposure circumstances
• Consistency of the history
• Recurrent unexplained exposures
• Overall safeguarding concerns

Important Modernization of the Older Source

• Amphetamines primarily increase catecholamine and dopamine signaling rather than simply acting as direct α/β agonists.
• The classic presentation is a sympathomimetic toxidrome.
• Severe hyperthermia is a medical emergency and can rapidly cause rhabdomyolysis, liver failure, coagulopathy, AKI, and brain injury.
• Benzodiazepines are foundational treatment for agitation and seizures.
• Antipyretics do not treat stimulant-induced hyperthermia.
• Phenytoin is generally not preferred for toxicologic seizures.
• Paralysis does not treat cerebral seizure activity and must never substitute for sedation.
• Hypertension often improves after adequate sedation.
• Modern evidence does not support an absolute blanket prohibition on every β-blocker in all stimulant-associated cardiovascular presentations.
• Trendelenburg positioning and routine dopamine-first shock treatment are outdated.
• Routine urinary alkalinization is not recommended for rhabdomyolysis.
• Urine amphetamine screens can be misleading and do not measure severity.
• Routine gastric lavage is obsolete.
• Activated charcoal has only a selective role after recent oral exposure with a safe airway.
• CT is generally more sensitive than plain radiography for body-packet detection.
• There is no specific antidote.
• Observation should be formulation- and symptom-based rather than a universal 4–6-hour rule.

Key Points

• Amphetamines → catecholamine excess → sympathomimetic toxidrome.
• Think agitation + tachycardia + hypertension + mydriasis + diaphoresis + hyperthermia.
• Benzodiazepines are first-line for significant agitation and seizures.
• Severe hyperthermia requires rapid sedation and active cooling.
• Major complications include seizures, stroke, myocardial ischemia, dysrhythmias, rhabdomyolysis, AKI, hepatic injury, and coagulopathy.
• Urine drug screens confirm neither current intoxication nor severity.
• Treat hypertension initially by controlling the hyperadrenergic state; persistent end-organ-threatening hypertension may require titratable cardiovascular therapy.
• Do not induce vomiting or routinely perform gastric lavage.
• No specific antidote exists.